A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
Clinical trial NCT02624167 · COMPLETED
Trial details
- NCT number
- NCT02624167
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-12-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.